Mid-Priced Biotechnology Companies Bloom As M&A Targets in 2013

Embedded Link

Mid-Priced Biotechnology Companies Bloom As M&A Targets in 2013 | Xconomy
At the annual health care conference run by JP Morgan in San Francisco this week, and at satellite events surrounding it every year, hundreds of biotechnol

Google+: View post on Google+

Tags:

Comments are closed.